Siemens launches syngo medical imaging platform for virtual simulation in oncology

Montréal 15 July 2002The Siemens Medical Solutions Oncology Care Systems Group introduced syngo for oncology applications at the 44th Annual Meeting of the American Association of Physicists in Medicine (AAPM). This annual educational meeting was held July 14-18 at the Palais des Congrès de Montréal. Siemens demonstrated syngo, the company's patented, universal software platform for medical imaging, used in virtual simulation, an integral oncology application. In keeping with its commitment to an open architecture philosophy, Siemens also showed a syngo connection with the treatment planning systems of various vendors attending AAPM.

Advertisement

"The syngo application for virtual simulation is the first of our Oncology Workflow Solutions to address problems currently facing clinicians, such as optimising operational and clinical outcomes in oncology care", stated Dr. Ajit Singh, president of the Siemens Oncology Care Systems Group. "The practice of radiation oncology is becoming increasingly dependent upon imaging to assist with the planning and delivery of more complex treatments. Syngo is the enabler that will streamline imaging capabilities for oncology practices."

Syngo is Siemens universal software platform for medical imaging, which empowers health care professionals with tools to streamline their clinical work flow by enabling seamless information exchange. The intuitive and common interface and straightforward connectivity of syngo provides ease of use and efficiency to the daily clinical routine, along with a truly integrated solution for virtual simulation. Customers have assured investment protection with syngo-based systems since new, state-of-the-art applications can be readily integrated.

Continuing its focus on medical imaging at AAPM, Siemens also showed its biograph molecular imager, a combination of PET and CT, and the PRIMATOM system, a combination of a CT on rails and a PRIMUS Linear Accelerator. Each of these syngo-speaking systems plays an important role in the diagnosis, treatment and follow-up of cancer, and demonstrates the Siemens commitment to its Seek-Find-Act-Follow initiative. Syngo for use in virtual simulation is pending 510(k) review and is not commercially available at this time.

Siemens Medical Solutions of Siemens AG with headquarters in Iselin, New Jersey and Erlangen, Germany, is one of the largest suppliers to the health care industry in the world. The company is renowned for its innovative products, including imaging systems for diagnosis, therapy equipment for treatment, hearing instruments, and critical care and life support systems, as well as a wide array of information technology and data management solutions that optimise work flow and increase efficiency in hospitals, clinics and doctors' offices. The company is known as the premier Application Service Provider processing more than 116 million transactions daily and managing more than 67 terabytes of data, twice the information volume of the Library of Congress.

Headquartered in Concord, California, the Oncology Care Systems Group of Siemens Medical Solutions develops and markets a broad range of custom solutions for the oncology market, comprising radiation therapy equipment and information technology products. The company's recently launched Seek-Find-Act-Follow Oncology Workflow Solutions initiative demonstrates that Siemens can provide a full range of oncology solutions from screening and diagnosis, through treatment and follow up.


Leslie Versweyveld

[Medical IT News][Calendar][Virtual Medical Worlds Community][News on Advanced IT]